A detailed history of Beacon Capital Management, LLC transactions in Dexcom Inc stock. As of the latest transaction made, Beacon Capital Management, LLC holds 17 shares of DXCM stock, worth $1,364. This represents 0.0% of its overall portfolio holdings.

Number of Shares
17
Previous 4 325.0%
Holding current value
$1,364
Previous $0 Infinity%
% of portfolio
0.0%
Previous 0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 07, 2024

BUY
$64.0 - $116.06 $832 - $1,508
13 Added 325.0%
17 $1,000
Q1 2024

May 16, 2024

SELL
$114.22 - $140.1 $1,370 - $1,681
-12 Reduced 75.0%
4 $0
Q3 2022

Oct 05, 2022

BUY
$76.35 - $94.18 $916 - $1,130
12 Added 300.0%
16 $1,000
Q1 2022

May 16, 2022

BUY
$94.08 - $130.2 $376 - $520
4 New
4 $3,000

Others Institutions Holding DXCM

About DEXCOM INC


  • Ticker DXCM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 386,257,984
  • Market Cap $31B
  • Description
  • DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...
More about DXCM
Track This Portfolio

Track Beacon Capital Management, LLC Portfolio

Follow Beacon Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Beacon Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Beacon Capital Management, LLC with notifications on news.